Clinical trial
Evaluation of the GORE® ACUSEAL Vascular Graft for Hemodialysis Access (ACUSEAL, AVG 08-06)
NCT01173718 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the GORE® ACUSEAL Vascular Graft for Hemodialysis Access (ACUSEAL, AVG 08-06)
- Lead sponsor
- W.L.Gore & Associates
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- February 28, 2013
- Enrollment
- 138 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease